These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8691436)

  • 1. Chemical synthesis of benzamide adenine dinucleotide: inhibition of inosine monophosphate dehydrogenase (types I and II).
    Zatorski A; Watanabe KA; Carr SF; Goldstein BM; Pankiewicz KW
    J Med Chem; 1996 Jun; 39(12):2422-6. PubMed ID: 8691436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The practical synthesis of a methylenebisphosphonate analogue of benzamide adenine dinucleotide: inhibition of human inosine monophosphate dehydrogenase (type I and II).
    Pankiewicz KW; Lesiak K; Zatorski A; Goldstein BM; Carr SF; Sochacki M; Majumdar A; Seidman M; Watanabe KA
    J Med Chem; 1997 Apr; 40(8):1287-91. PubMed ID: 9111303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.
    Lesiak K; Watanabe KA; Majumdar A; Seidman M; Vanderveen K; Goldstein BM; Pankiewicz KW
    J Med Chem; 1997 Aug; 40(16):2533-8. PubMed ID: 9258359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.
    Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Jayaprakasan V; Jayaram HN; Boyd DB; Jain MD; Grifantini M
    Bioorg Med Chem; 2005 Mar; 13(6):2045-53. PubMed ID: 15727858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.
    Rejman D; Olesiak M; Chen L; Patterson SE; Wilson D; Jayaram HN; Hedstrom L; Pankiewicz KW
    J Med Chem; 2006 Aug; 49(16):5018-22. PubMed ID: 16884314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.
    Lesiak K; Watanabe KA; Majumdar A; Powell J; Seidman M; Vanderveen K; Goldstein BM; Pankiewicz KW
    J Med Chem; 1998 Feb; 41(4):618-22. PubMed ID: 9484510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.
    Chen L; Petrelli R; Olesiak M; Wilson DJ; Labello NP; Pankiewicz KW
    Bioorg Med Chem; 2008 Aug; 16(15):7462-9. PubMed ID: 18583139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibitors of human inosine monophosphate dehydrogenase type II. Fluorine-substituted analogues of thiazole-4-carboxamide adenine dinucleotide.
    Zatorski A; Goldstein BM; Colby TD; Jones JP; Pankiewicz KW
    J Med Chem; 1995 Mar; 38(7):1098-105. PubMed ID: 7707313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis.
    Bonnac L; Gao GY; Chen L; Felczak K; Bennett EM; Xu H; Kim T; Liu N; Oh H; Tonge PJ; Pankiewicz KW
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4588-91. PubMed ID: 17560106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of isosteric analogues of nicotinamide adenine dinucleotide containing C-nucleotide of nicotinamide or picolinamide.
    Pankiewicz KW; Zeidler J; Ciszewski LA; Bell JE; Goldstein BM; Jayaram HN; Watanabe KA
    J Med Chem; 1993 Jun; 36(13):1855-9. PubMed ID: 8099976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing Aplysia californica adenosine 5'-diphosphate ribosyl cyclase for substrate binding requirements: design of potent inhibitors.
    Migaud ME; Pederick RL; Bailey VC; Potter BV
    Biochemistry; 1999 Jul; 38(28):9105-14. PubMed ID: 10413485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues.
    Chen L; Gao G; Felczak K; Bonnac L; Patterson SE; Wilson D; Bennett EM; Jayaram HN; Hedstrom L; Pankiewicz KW
    J Med Chem; 2007 Nov; 50(23):5743-51. PubMed ID: 17958343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside.
    Jäger W; Salamon A; Szekeres T
    Curr Med Chem; 2002 Apr; 9(7):781-6. PubMed ID: 11966442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor.
    Chen L; Gao G; Bonnac L; Wilson DJ; Bennett EM; Jayaram HN; Pankiewicz KW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3152-5. PubMed ID: 17395461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correspondence analysis of protein kinase C (PKC) inhibition by bis-basic substituted benzamides.
    Gilbert J; Cheminant M; Bignon E; Pons M; Ojasoo T; Doré JC
    Drug Des Discov; 1998 Oct; 15(4):253-67. PubMed ID: 10546070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
    Pankiewicz KW; Lesiak-Watanabe KB; Watanabe KA; Patterson SE; Jayaram HN; Yalowitz JA; Miller MD; Seidman M; Majumdar A; Prehna G; Goldstein BM
    J Med Chem; 2002 Jan; 45(3):703-12. PubMed ID: 11806722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical consequences of resistance to a recently discovered IMP dehydrogenase inhibitor, benzamide riboside, in human myelogenous leukemia K562 cells.
    Jayaram HN; O'Connor A; Grant MR; Yang H; Grieco PA; Cooney DA
    J Exp Ther Oncol; 1996 Sep; 1(5):278-85. PubMed ID: 9414415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing binding requirements of NAD kinase with modified substrate (NAD) analogues.
    Bonnac L; Chen L; Pathak R; Gao G; Ming Q; Bennett E; Felczak K; Kullberg M; Patterson SE; Mazzola F; Magni G; Pankiewicz KW
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1512-5. PubMed ID: 17258457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.
    Birch HL; Buckley GM; Davies N; Dyke HJ; Frost EJ; Gilbert PJ; Hannah DR; Haughan AF; Madigan MJ; Morgan T; Pitt WR; Ratcliffe AJ; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5335-9. PubMed ID: 16202581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells.
    Grusch M; Rosenberger G; Fuhrmann G; Braun K; Titscher B; Szekeres T; Fritzer-Skekeres M; Oberhuber G; Krohn K; Hengstschlaeger M; Krupitza G; Jayaram HN
    Cell Death Differ; 1999 Aug; 6(8):736-44. PubMed ID: 10467347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.